| Dr Christopher James Macdonald, MD, PHD | |
|
11995 Singletree Ln Ste 500, Eden Prairie, MN 55344-5349 | |
| (952) 595-1301 | |
| (612) 294-4903 |
| Full Name | Dr Christopher James Macdonald |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 12 Years |
| Location | 11995 Singletree Ln Ste 500, Eden Prairie, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043567530 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 62101 (Wisconsin) | Secondary |
| 2085R0202X | Radiology - Diagnostic Radiology | 55510 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arizona Diagnostic Radiology Group Llc | 1658796859 | 60 |
| Beverly Radiology Medical Group Iii | 3476466376 | 242 |
| Desert Advanced Imaging Medical Center | 6406749613 | 133 |
| Beverly Radiology Medical Group Iii | 3476466376 | 242 |
News Archive
PharmAthene, Inc. a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, announced today that the Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority has modified its existing research and development contract with PharmAthene providing for up to a total of $78.4 million in additional funding, provided that certain milestones are achieved and that all contract options and extensions are exercised by the government, to support the continued advanced development of SparVax™, a second generation recombinant protective antigen (rPA) anthrax vaccine targeted for future procurement in the U.S. Strategic National Stockpile.
Proteome analysis, a screening requiring only a patient's urine specimen, shows promise as a reliable and noninvasive way to diagnose atherosclerosis and coronary artery disease in the future, according to research presented at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference 2009.
A new peer-reviewed, published study shows French maritime pine bark extract, Pycnogenol, may be effective in curbing muscle loss that occurs with aging – a natural process that leads to sarcopenia, a common condition affecting adults as early as age 65.
Reinforcing General Mills' on-going commitment to helping Americans achieve a healthy weight through energy balance, the company joined retailers, non-government organizations and peer food and beverage manufacturers today to launch the Healthy Weight Commitment Foundation (HWCF).
› Verified 1 days ago
| Entity Name | Beverly Radiology Medical Group Iii |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962457812 PECOS PAC ID: 3476466376 Enrollment ID: O20141029002601 |
News Archive
PharmAthene, Inc. a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, announced today that the Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority has modified its existing research and development contract with PharmAthene providing for up to a total of $78.4 million in additional funding, provided that certain milestones are achieved and that all contract options and extensions are exercised by the government, to support the continued advanced development of SparVax™, a second generation recombinant protective antigen (rPA) anthrax vaccine targeted for future procurement in the U.S. Strategic National Stockpile.
Proteome analysis, a screening requiring only a patient's urine specimen, shows promise as a reliable and noninvasive way to diagnose atherosclerosis and coronary artery disease in the future, according to research presented at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference 2009.
A new peer-reviewed, published study shows French maritime pine bark extract, Pycnogenol, may be effective in curbing muscle loss that occurs with aging – a natural process that leads to sarcopenia, a common condition affecting adults as early as age 65.
Reinforcing General Mills' on-going commitment to helping Americans achieve a healthy weight through energy balance, the company joined retailers, non-government organizations and peer food and beverage manufacturers today to launch the Healthy Weight Commitment Foundation (HWCF).
› Verified 1 days ago
| Entity Name | Desert Advanced Imaging Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568416147 PECOS PAC ID: 6406749613 Enrollment ID: O20170120001843 |
News Archive
PharmAthene, Inc. a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, announced today that the Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority has modified its existing research and development contract with PharmAthene providing for up to a total of $78.4 million in additional funding, provided that certain milestones are achieved and that all contract options and extensions are exercised by the government, to support the continued advanced development of SparVax™, a second generation recombinant protective antigen (rPA) anthrax vaccine targeted for future procurement in the U.S. Strategic National Stockpile.
Proteome analysis, a screening requiring only a patient's urine specimen, shows promise as a reliable and noninvasive way to diagnose atherosclerosis and coronary artery disease in the future, according to research presented at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference 2009.
A new peer-reviewed, published study shows French maritime pine bark extract, Pycnogenol, may be effective in curbing muscle loss that occurs with aging – a natural process that leads to sarcopenia, a common condition affecting adults as early as age 65.
Reinforcing General Mills' on-going commitment to helping Americans achieve a healthy weight through energy balance, the company joined retailers, non-government organizations and peer food and beverage manufacturers today to launch the Healthy Weight Commitment Foundation (HWCF).
› Verified 1 days ago
| Entity Name | Geisinger Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558313023 PECOS PAC ID: 5395657001 Enrollment ID: O20180801002886 |
News Archive
PharmAthene, Inc. a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, announced today that the Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority has modified its existing research and development contract with PharmAthene providing for up to a total of $78.4 million in additional funding, provided that certain milestones are achieved and that all contract options and extensions are exercised by the government, to support the continued advanced development of SparVax™, a second generation recombinant protective antigen (rPA) anthrax vaccine targeted for future procurement in the U.S. Strategic National Stockpile.
Proteome analysis, a screening requiring only a patient's urine specimen, shows promise as a reliable and noninvasive way to diagnose atherosclerosis and coronary artery disease in the future, according to research presented at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference 2009.
A new peer-reviewed, published study shows French maritime pine bark extract, Pycnogenol, may be effective in curbing muscle loss that occurs with aging – a natural process that leads to sarcopenia, a common condition affecting adults as early as age 65.
Reinforcing General Mills' on-going commitment to helping Americans achieve a healthy weight through energy balance, the company joined retailers, non-government organizations and peer food and beverage manufacturers today to launch the Healthy Weight Commitment Foundation (HWCF).
› Verified 1 days ago
| Entity Name | Geisinger-hm Joint Venture Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396207015 PECOS PAC ID: 1355676370 Enrollment ID: O20200226001693 |
News Archive
PharmAthene, Inc. a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, announced today that the Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority has modified its existing research and development contract with PharmAthene providing for up to a total of $78.4 million in additional funding, provided that certain milestones are achieved and that all contract options and extensions are exercised by the government, to support the continued advanced development of SparVax™, a second generation recombinant protective antigen (rPA) anthrax vaccine targeted for future procurement in the U.S. Strategic National Stockpile.
Proteome analysis, a screening requiring only a patient's urine specimen, shows promise as a reliable and noninvasive way to diagnose atherosclerosis and coronary artery disease in the future, according to research presented at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference 2009.
A new peer-reviewed, published study shows French maritime pine bark extract, Pycnogenol, may be effective in curbing muscle loss that occurs with aging – a natural process that leads to sarcopenia, a common condition affecting adults as early as age 65.
Reinforcing General Mills' on-going commitment to helping Americans achieve a healthy weight through energy balance, the company joined retailers, non-government organizations and peer food and beverage manufacturers today to launch the Healthy Weight Commitment Foundation (HWCF).
› Verified 1 days ago
| Entity Name | Arizona Diagnostic Radiology Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336757699 PECOS PAC ID: 1658796859 Enrollment ID: O20200805001519 |
News Archive
PharmAthene, Inc. a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, announced today that the Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority has modified its existing research and development contract with PharmAthene providing for up to a total of $78.4 million in additional funding, provided that certain milestones are achieved and that all contract options and extensions are exercised by the government, to support the continued advanced development of SparVax™, a second generation recombinant protective antigen (rPA) anthrax vaccine targeted for future procurement in the U.S. Strategic National Stockpile.
Proteome analysis, a screening requiring only a patient's urine specimen, shows promise as a reliable and noninvasive way to diagnose atherosclerosis and coronary artery disease in the future, according to research presented at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference 2009.
A new peer-reviewed, published study shows French maritime pine bark extract, Pycnogenol, may be effective in curbing muscle loss that occurs with aging – a natural process that leads to sarcopenia, a common condition affecting adults as early as age 65.
Reinforcing General Mills' on-going commitment to helping Americans achieve a healthy weight through energy balance, the company joined retailers, non-government organizations and peer food and beverage manufacturers today to launch the Healthy Weight Commitment Foundation (HWCF).
› Verified 1 days ago
| Entity Name | Mary Imogene Bassett Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083664221 PECOS PAC ID: 3779488325 Enrollment ID: O20210119001599 |
News Archive
PharmAthene, Inc. a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, announced today that the Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority has modified its existing research and development contract with PharmAthene providing for up to a total of $78.4 million in additional funding, provided that certain milestones are achieved and that all contract options and extensions are exercised by the government, to support the continued advanced development of SparVax™, a second generation recombinant protective antigen (rPA) anthrax vaccine targeted for future procurement in the U.S. Strategic National Stockpile.
Proteome analysis, a screening requiring only a patient's urine specimen, shows promise as a reliable and noninvasive way to diagnose atherosclerosis and coronary artery disease in the future, according to research presented at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference 2009.
A new peer-reviewed, published study shows French maritime pine bark extract, Pycnogenol, may be effective in curbing muscle loss that occurs with aging – a natural process that leads to sarcopenia, a common condition affecting adults as early as age 65.
Reinforcing General Mills' on-going commitment to helping Americans achieve a healthy weight through energy balance, the company joined retailers, non-government organizations and peer food and beverage manufacturers today to launch the Healthy Weight Commitment Foundation (HWCF).
› Verified 1 days ago
| Entity Name | Palm Desert Radiology Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124079868 PECOS PAC ID: 0749173789 Enrollment ID: O20230427001791 |
News Archive
PharmAthene, Inc. a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, announced today that the Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority has modified its existing research and development contract with PharmAthene providing for up to a total of $78.4 million in additional funding, provided that certain milestones are achieved and that all contract options and extensions are exercised by the government, to support the continued advanced development of SparVax™, a second generation recombinant protective antigen (rPA) anthrax vaccine targeted for future procurement in the U.S. Strategic National Stockpile.
Proteome analysis, a screening requiring only a patient's urine specimen, shows promise as a reliable and noninvasive way to diagnose atherosclerosis and coronary artery disease in the future, according to research presented at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference 2009.
A new peer-reviewed, published study shows French maritime pine bark extract, Pycnogenol, may be effective in curbing muscle loss that occurs with aging – a natural process that leads to sarcopenia, a common condition affecting adults as early as age 65.
Reinforcing General Mills' on-going commitment to helping Americans achieve a healthy weight through energy balance, the company joined retailers, non-government organizations and peer food and beverage manufacturers today to launch the Healthy Weight Commitment Foundation (HWCF).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Christopher James Macdonald, MD, PHD 11995 Singletree Ln Ste 500, Eden Prairie, MN 55344-5349 Ph: (952) 595-1301 | Dr Christopher James Macdonald, MD, PHD 11995 Singletree Ln Ste 500, Eden Prairie, MN 55344-5349 Ph: (952) 595-1301 |
News Archive
PharmAthene, Inc. a biodefense company specializing in the development and commercialization of medical countermeasures against chemical and biological threats, announced today that the Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority has modified its existing research and development contract with PharmAthene providing for up to a total of $78.4 million in additional funding, provided that certain milestones are achieved and that all contract options and extensions are exercised by the government, to support the continued advanced development of SparVax™, a second generation recombinant protective antigen (rPA) anthrax vaccine targeted for future procurement in the U.S. Strategic National Stockpile.
Proteome analysis, a screening requiring only a patient's urine specimen, shows promise as a reliable and noninvasive way to diagnose atherosclerosis and coronary artery disease in the future, according to research presented at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference 2009.
A new peer-reviewed, published study shows French maritime pine bark extract, Pycnogenol, may be effective in curbing muscle loss that occurs with aging – a natural process that leads to sarcopenia, a common condition affecting adults as early as age 65.
Reinforcing General Mills' on-going commitment to helping Americans achieve a healthy weight through energy balance, the company joined retailers, non-government organizations and peer food and beverage manufacturers today to launch the Healthy Weight Commitment Foundation (HWCF).
› Verified 1 days ago
Norna L. Karp, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 11995 Singletree Ln Ste 500, Eden Prairie, MN 55344 Phone: 952-595-1301 Fax: 612-294-4903 | |
Paul D Guisler, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 11995 Singletree Ln Ste 500, Eden Prairie, MN 55344 Phone: 952-595-1301 Fax: 612-294-4903 | |
Rati N Patel, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 11995 Singletree Ln Ste 500, Eden Prairie, MN 55344 Phone: 952-595-1301 Fax: 612-294-4903 | |
Jacob Gebrael, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 11995 Singletree Ln Ste 500, Eden Prairie, MN 55344 Phone: 952-595-1301 Fax: 612-294-4903 | |
Susanne S. Kim, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 11995 Singletree Ln Ste 500, Eden Prairie, MN 55344 Phone: 952-595-1301 Fax: 612-294-4903 | |
Gwendolyn Durgin, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 11995 Singletree Ln Ste 500, Eden Prairie, MN 55344 Phone: 952-595-1301 Fax: 612-294-4903 | |
Stephen George Fox, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 11995 Singletree Ln Ste 500, Eden Prairie, MN 55344 Phone: 952-595-1301 Fax: 612-294-4903 |